Home » Topics » Conferences

Conferences
RSS

Preclinical efficacy in multiple gastrointestinal disorders reported for ALX-0600

May 22, 1998

MDX-210 shows significant antitumor activity in prostate and kidney cancer patients

May 22, 1998

Renal effects of BG-9719 demonstrated in CHF patients and healthy volunteers

May 22, 1998

IRFI-165, an adenosine antagonist for the treatment of depression

May 21, 1998

Alosetron emerging as safe and effective treatment for IBS in female patients

May 21, 1998

NO-releasing NSAID protects against gastric mucosal damage: in vitro and in vivo studies

May 21, 1998

IRFI-117, an adenosine A1 antagonist for oral or i.v. dosing

May 21, 1998

NO-NSAIDs retain antiinflammatory/analgesic potency, with fewer GI side effects

May 20, 1998

DEHOP phase II data discussed at Digestive Disease Week

May 20, 1998

S-Nitrosocaptopril combines NO-donor and ACE-inhibitor effects in a single molecule

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...